| Metric | Value | Detail |
|---|---|---|
| Revenue | $94.2B | +6.0% YoY |
| Net income | $26.8B | 28.5% margin |
| Gross margin | 67.9% | Gross profit / revenue |
| Operating margin | n/a | No operating income line in the SEC data |
| Return on equity | 33% | Net income / equity |
| Return on assets | 13% | Net income / assets |
| Revenue growth (YoY) | +6.0% | FY2024 to FY2025 |
| Revenue 3-yr CAGR | +6.2% | Compound annual |
| Diluted EPS | $11.03 | FY2025 |
| Debt-to-equity | 0.48 | Long-term debt / equity |
| Current ratio | 1.03 | Current assets / liabilities |
| Cash & equivalents | $19.7B | Balance sheet |
| Total assets | $199.2B | FY2025 year-end |
| Shareholders’ equity | $81.5B | FY2025 year-end, incl. noncontrolling interests |
| Share price | $255.41 | Delayed · 2026-10-02 |
| Market cap | $615.5B | Price × shares outstanding |
| P/E ratio | 23.0 | Market cap / net income |
| P/S ratio | 6.5 | Market cap / revenue |
| Dividend yield | 2.01% | Dividend / price |
Stock fundamentals · FY2025 · SEC 10-K data
Johnson & Johnson (JNJ) stock fundamentals
Johnson & Johnson (JNJ) reported $94.2B in revenue and $26.8B in net income in fiscal 2025, a 28.5% net margin, per its latest SEC 10-K filing. It carries a market capitalization of about $615.5B at a delayed share price. It scores 65/100 on WealthyBud's Investor Score, ranking #18 of 103 covered companies. Score is research, not investment advice.
Revenue (FY2025)
$94.2B
▲ +6.0% YoY
Net income
$26.8B
28.5% net margin
Market cap
$615.5B
Price $255.41 · delayed
P/E ratio
23.0
Price / earnings
Return on equity
33%
Net income / equity
Investor Score
65/100
#18 of 103 covered
Johnson & Johnson fundamentals at a glance
The table summarizes Johnson & Johnson's key financial figures for fiscal 2025 — revenue, profitability, returns, growth and balance-sheet strength — each taken from the company's SEC 10-K filing.
How profitable is Johnson & Johnson?
Johnson & Johnson posted a 28.5% net margin and a 67.9% gross margin in fiscal 2025, turning $94.2B of revenue into $26.8B of net income. Its return on equity was 33% and its return on assets 13%.
Is Johnson & Johnson growing?
Johnson & Johnson's revenue changed +6.0% in fiscal 2025 and compounded at +6.2% a year over three years, reaching $94.2B. Diluted earnings per share were $11.03 for the year.
| Fiscal year | Revenue | Growth |
|---|---|---|
| 2021 | $82.6B | First year shown |
| 2022 | $78.7B | -4.7% |
| 2023 | $85.2B | +8.2% |
| 2024 | $88.8B | +4.3% |
| 2025 | $94.2B | +6.0% |
How is Johnson & Johnson valued?
Johnson & Johnson carries a market capitalization of $615.5B at a delayed share price of $255.41. It trades at 23.0 times earnings and 6.5 times sales. Its dividend yield is 2.01%. Its Value subscore is 50/100 across the covered universe.
How financially healthy is Johnson & Johnson?
Johnson & Johnson ended fiscal 2025 with $19.7B in cash, a debt-to-equity ratio of 0.48 and a current ratio of 1.03. Lower leverage and a current ratio above 1.0 signal a stronger balance sheet.
What is Johnson & Johnson's Investor Score?
Johnson & Johnson scores 65/100 on WealthyBud's Investor Score, #18 of 103 covered companies as of 2026-10-02. The score blends growth, profitability, returns on capital, balance-sheet strength and value into one percentile. It is a research opinion, not investment advice.
Investor Score
65/100
#18 of 103 covered companies
Subscores are percentile ranks (0–100) across the 103 covered companies, computed from the SEC fundamentals and delayed market price cited on this page. Data-derived opinion, not investment advice.
Johnson & Johnson (JNJ) stock FAQ
How much revenue does Johnson & Johnson make?
Johnson & Johnson (JNJ) reported $94.2B in revenue in fiscal 2025, +6.0% versus the prior year, according to its SEC 10-K filing. Its revenue compounded at +6.2% a year over three years.
Is Johnson & Johnson profitable?
Yes. Johnson & Johnson earned $26.8B in net income in fiscal 2025, a 28.5% net margin. Its return on equity was 33% and its return on assets 13%. These figures come from its latest 10-K.
How fast is Johnson & Johnson growing?
Johnson & Johnson's revenue changed +6.0% year over year in fiscal 2025 and compounded at +6.2% a year over three years. Growth is one of five inputs to its WealthyBud Investor Score, scored 64/100 versus the covered universe.
What is Johnson & Johnson's market cap and P/E ratio?
Johnson & Johnson has a market capitalization of $615.5B at a delayed share price of $255.41. It trades at 23.0 times earnings and 6.5 times sales. Its dividend yield is 2.01%. Prices are delayed and illustrative.
What is Johnson & Johnson's WealthyBud Investor Score?
Johnson & Johnson scores 65/100, ranking #18 of 103 covered companies as of 2026-10-02. The score is a percentile blend of growth (64), profitability (78), returns on capital (72), balance-sheet strength (49) and value (50). It is a research opinion, not investment advice.
Where does this Johnson & Johnson financial data come from?
Fundamentals come from Johnson & Johnson's annual report (Form 10-K) filed with the SEC, via the public-domain EDGAR database. The share price used for market cap, P/E and yield is a delayed end-of-day quote, shown as illustrative; a production site would use a licensed real-time market-data feed.
Fundamentals are drawn from Johnson & Johnson’s FY2025 Form 10-K filed with the
SEC (EDGAR, public domain), retrieved 2026-10-02. Share price is a delayed end-of-day quote; market cap, P/E, P/S
and dividend yield are illustrative and not real-time. The Investor Score is a data-derived research opinion.
Not investment advice.
Related
More large-cap stocks
Stocks
INTEL CORP (INTC)
$604.2B market cap · Investor Score 17/100
View StocksVISA INC. (V)
$643.9B market cap · Investor Score 71/100
View StocksMastercard Incorporated (MA)
$485.2B market cap · Investor Score 70/100
View ResearchU.S. Stock Market Statistics (2026)
Market cap, valuation and concentration data across the U.S. stock market.
View